Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mast cells initiate lymphocyte egress from distant lymph nodes upon skin inflammation via RANKL/sphingosine-1-phosphate axis
Konstantinos Katsoulis-Dimitriou, Waqar Umer, Laura Knop, Tanja Schickschneit, Aaron Hoffmann, Ali El-Bizri, Lea M. Schmitter, Kathleen Baumgart, Nouria Jantz-Naeem, Vladyslava Dovhan, Charlotte Heidelbach, Lars Philipsen, Andreas J Müller, Stephan Fricke, Sascha Kahlfuß, Thomas Schüler, Jan Dudeck, Anne Dudeck
Konstantinos Katsoulis-Dimitriou, Waqar Umer, Laura Knop, Tanja Schickschneit, Aaron Hoffmann, Ali El-Bizri, Lea M. Schmitter, Kathleen Baumgart, Nouria Jantz-Naeem, Vladyslava Dovhan, Charlotte Heidelbach, Lars Philipsen, Andreas J Müller, Stephan Fricke, Sascha Kahlfuß, Thomas Schüler, Jan Dudeck, Anne Dudeck
View: Text | PDF
Research Article Dermatology Immunology Inflammation

Mast cells initiate lymphocyte egress from distant lymph nodes upon skin inflammation via RANKL/sphingosine-1-phosphate axis

  • Text
  • PDF
Abstract

Receptor activator of NF-κB ligand (RANKL) is important for bone metabolism, but also modulates immune processes. We showed that mast cells (MCs) were involved in RANKL regulation, but the importance of MC-derived RANKL in skin inflammation has not, to our knowledge, been investigated. In contact hypersensitivity (CHS), the absence of MC-derived RANKL led to reduced skin inflammation due to impaired leukocyte infiltration and blood lymphopenia. Surprisingly, we observed a massive hyperplasia of the distant inguinal lymph nodes (LNs) in the absence of MC RANKL. Using adoptive transfers, flow cytometry, and whole-mount 3D imaging, we demonstrated that this was not caused by structural maladaptation, but rather by the inability of lymphocytes to exit in a timely manner. Importantly, RANKL deletion in skin MCs only replicated the effect of LN hyperplasia and blood lymphopenia. Moreover, MCs were involved in serum sphingosine-1-phosphate (S1P) regulation during sensitization and challenge. Intravascular administration of S1P restored timely lymphocyte egress, demonstrating a MC-induced, organ-spanning RANKL/S1P axis. Consequently, peripheral skin MC–derived RANKL was essential for the timely lymphocyte egress from distant LNs, which may have important implications for the targeted treatment of inflammatory skin diseases.

Authors

Konstantinos Katsoulis-Dimitriou, Waqar Umer, Laura Knop, Tanja Schickschneit, Aaron Hoffmann, Ali El-Bizri, Lea M. Schmitter, Kathleen Baumgart, Nouria Jantz-Naeem, Vladyslava Dovhan, Charlotte Heidelbach, Lars Philipsen, Andreas J Müller, Stephan Fricke, Sascha Kahlfuß, Thomas Schüler, Jan Dudeck, Anne Dudeck

×

Figure 3

Inguinal LN hyperplasia in MCΔRANKL mice is transient and driven by tissue effects.

Options: View larger image (or click on image) Download as PowerPoint
Inguinal LN hyperplasia in MCΔRANKL mice is transient and driven by tiss...
(A) MCΔRANKL or MCWT mice as well as WT mice were sensitized on the back skin for 6 days. Lymphocytes were isolated from spleens and LNs of sensitized WT mice, labeled with CFSE, and adoptively transferred into MCΔRANKL or MCWT mice 1 day after sensitization. Five days later, flow cytometric analysis of LN lymphocytes was performed. (B) Total numbers of lymphocytes in the inguinal LN. (C) Numbers of CFSE+-labeled lymphocyte subsets in inguinal LNs of recipient mice. (D) Mice were sensitized on the back skin with DNFB, and total leukocyte numbers were evaluated by flow cytometry on days 4, 6, and 10. Kinetics assay of inguinal LNi lymphocyte numbers at days 4, 6, and 10 after sensitization. (E) Kinetics assay of blood lymphocyte numbers, per 100 μL blood, at days 4, 6, and 10 after sensitization. (F) Blood lymphocyte numbers per 100 μL blood at day 10 after sensitization. All graphs are depicted as the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001, by Kruskal-Wallis test (B, C, and F) or 2-way ANOVA (D and E), both with correction for multiple comparisons.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts